Likely FDA approval for postpartum depression drug pushes Sage Pharmaceuticals stock up 40%
November 10, 2017 at 15:05 PM EST
Analysts gave the company an 80 percent likelihood of success for FDA approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.